Novis, Elan
van Akkooi, Alexander C. J.
Funding for this research was provided by:
University of Sydney
Article History
Accepted: 21 May 2024
First Online: 6 June 2024
Declarations
:
: EN has no conflicts of interest to disclose. AvA declares: <b>Advisory Board/Consultancy Honoraria </b>4SC AG, Amgen, Bristol-Myers Squibb, Merck Serono-Pfizer, MSD-Merck, Neracare, Novartis, Pierre Fabre, Sanofi, Sirius Medical, SkylineDX.
: This article does not contain any studies with human or animal subjects performed by any of the authors.